Market Cap

Heilongjiang ZBD Pharmaceutical Co. Ltd Market Capitalization:

CN¥10.39 Billion

CNY as of July 1, 2024

US$1.43 Billion

business Heilongjiang ZBD Pharmaceutical Co. Ltd Company Profile

Heilongjiang ZBD Pharmaceutical Co. Ltd Main Stock Listing

SSE: 603567

Market Capitalization History of Heilongjiang ZBD Pharmaceutical Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Heilongjiang ZBD Pharmaceutical Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥11.48 B -1.93%
Jan. 1, 2023 CN¥11.71 B -8.68%
Jan. 1, 2022 CN¥12.82 B 28.83%
Jan. 1, 2021 CN¥9.95 B -18.02%
Jan. 1, 2020 CN¥12.14 B 7.29%
Jan. 1, 2019 CN¥11.32 B -16.44%
Jan. 1, 2018 CN¥13.54 B -23.94%
Jan. 1, 2017 CN¥17.80 B 2.71%
Jan. 1, 2016 CN¥17.33 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Heilongjiang ZBD Pharmaceutical Co. Ltd Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

Heilongjiang ZBD Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SSE: 603567

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.